Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

RGEN : 132.38 (+0.89%)
BAX : 18.74 (+0.16%)
CRL : 184.28 (+0.22%)
NVST : 28.02 (+0.65%)
SGRY : 14.12 (+0.86%)
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its...

RGEN : 132.38 (+0.89%)
1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Avoid

1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Avoid

PSTG : 67.80 (+4.48%)
RGEN : 132.38 (+0.89%)
LXFR : 12.81 (-0.93%)
1 Cash-Producing Stock Worth Your Attention and 2 We Avoid

1 Cash-Producing Stock Worth Your Attention and 2 We Avoid

SEDG : 38.76 (+1.20%)
INTU : 398.92 (+1.44%)
RGEN : 132.38 (+0.89%)
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

ILMN : 132.45 (-1.52%)
EVH : 2.91 (+2.46%)
RGEN : 132.38 (+0.89%)
CRL : 184.28 (+0.22%)
RDNT : 57.19 (-5.30%)
1 High-Flying Stock with Solid Fundamentals and 2 We Avoid

1 High-Flying Stock with Solid Fundamentals and 2 We Avoid

HLT : 342.15 (+0.33%)
COST : 1,002.14 (+0.23%)
RGEN : 132.38 (+0.89%)
1 Cash-Heavy Stock to Target This Week and 2 We Question

1 Cash-Heavy Stock to Target This Week and 2 We Question

NTRA : 209.06 (+0.32%)
RGEN : 132.38 (+0.89%)
REAX : 2.66 (-2.92%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

RGEN : 132.38 (+0.89%)
2 Growth Stocks Set to Flourishand 1 We Turn Down

2 Growth Stocks Set to Flourishand 1 We Turn Down

FTAI : 255.67 (-1.34%)
RGEN : 132.38 (+0.89%)
PANW : 168.59 (+0.44%)
3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar

DHI : 150.68 (+0.58%)
RGEN : 132.38 (+0.89%)
NMRK : 16.56 (+0.18%)

Barchart Exclusives

As Intel Releases Its Core Series 3 Processors, Should You Buy, Sell, or Hold INTC Stock?
Intel stock perked up after rolling out its latest processors with sharper AI chops. Is this a time to jump in or keep your powder dry? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.